Jianmin Pharmaceutical Group Co.,Ltd.

¥27.94As of Sun 8 Nov 2026, 12:00 UTC
SSE:600976Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (0.27%)
Div yield 3.22%
ROE 11.79%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.14
PE TTM 13.57
TSR TTM (27.15%)
Mkt cap ¥4.286B
ROIC 14.86%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥35
23.68%
238.03%
Hold 1|7|2|12|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.27
0.27
0.29
0.31
13.34%
7.56%
5.52%
12.89%
Revenue¥M
400.1
409.1
425.0
435.5
1.77%
4.73%
10.90%
11.27%
Peers (US$642.5M)
Cap (US$)
PE
652.7M
139.3x
631.5M
—
Capital
TTM
5Y
10Y
Leveragex
1.051
(0.213)
(0.229)
EBIT/Intx
16.95
0.184
0.164
Own earn%
(107.22)
90.12
100.19
Sh yield%
31.38
40.36
39.35
Owners
Insiders/Inst%
12.72
87.48
Short interest%
5.93
SBC / revenue%
4.92
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
25–37
$1 testx
—
Incr. ROIC%
34